The effect of prior docetaxel (DOC) treatment on efficacy and safety of apalutamide (APA) plus androgen deprivation therapy (ADT) in patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) from TITAN.

2022

Given, Robert

Chi, Kim N.

Merseburger, Axel S.

Ozguroglu, Mustafa

Chowdhury, Simon

Bjartell, Anders

Chung, Byung

Gomes, Andrea Juliana Pereira de Santana

Juarez, Alvaro

Uemura, Hirotsugu

Ye, Dingwei

Karsh, Lawrence Ivan

Gartrell, Benjamin Adam

Brookman-May, Sabine D.

Mundle, Suneel

McCarthy, Sharon Anne

Lefresne, Florence

Rooney, Oliver Brendan

Bhaumik, Amitabha

Agarwal, Neeraj